241958 ⎘
Chemistry: analytical and immunological testing Test for named disease, body condition or organ function
Sub-classes:Sample Collection and Analysis
#2DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#3Sample Collection and Analysis
#4Detection and treatment of autoimmune disorders
#5Method and devices for rapid diagnosis of foot-and-mouth disease
#6QUANTITATIVE ANALYTE ASSAY DEVICE AND METHOD
#7Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP
#8Devices and methods for detecting amniotic fluid in vaginal secretions
#9Sample collection and analysis
#10Quantitative analyte assay device and method
#11Sample collection and analysis
#12Methods for predicting pregnancy outcome in a subject by hCG assay
#13Device for the detection of an analyte in a fluid sample
#14Devices and methods for detecting amniotic fluid in vaginal secretions
#15Devices and methods for detecting amniotic fluid in vaginal secretions
#16Methods and kits for detecting ITA in a biological sample
#17HEALTH MONITORING AND DIAGNOSTIC DEVICE AND NETWORK-BASED HEALTH ASSESSMENT AND MEDICAL RECORDS MAINTENANCE SYSTEM
#18METHODS OF PREDICTING AND TREATING ADVERSE CARDIAC EVENTS
#19METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#20Retentate chromatography and protein chip arrays with applications in biology and medicine
#21NOVEL METHODS FOR THE ASSAY OF TROPONIN I AND T AND COMPLEXES OF TROPONIN I AND T AND SELECTION OF ANTIBODIES FOR USE IN IMMUNOASSAYS
#22IDENTIFICATION AND MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS
#23Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP
#24Post-translation modified cardiac troponin T as a biomarker of a risk for heart failure
#25Biomarkers for differentiating between type 1 and type 2 diabetes
#26Markers of renal transplant rejection and renal damage
#27PREWETTING LATERAL FLOW TEST STRIP
#28Methods for diagnosis of myelodysplastic syndromes (MDS)
#29Quantitative analyte assay device and method
#30Devices and methods for detecting amniotic fluid in vaginal secretions
#31Methods for differentiating and monitoring parathyroid and bone status related diseases
#32Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#33DIAGNOSING AND MONITORING INFLAMMATORY DISEASES BY MEASURING COMPLEMENT COMPONENTS ON WHITE BLOOD CELLS
#34Method for detecting lysosomal storage diseases
#35Methods for predicting pregnancy outcome in a subject by hCG assay
#36Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system
#37Biomarker and method for detecting a chronic inflammatory-associated disease
#38Methods and apparatus for screening for chromosomal abnormalities
#39Detection and monitoring of liver damage
#40Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy
#41Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism
#42Optical detection of label-free biomolecular interactions using microreplicated plastic
#43Methods and kits for detecting ITA in a biological sample
#44Detection and monitoring of liver damage
#45Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
#46Methods of predicting and treating adverse cardiac events
#47Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
#48Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#49Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
#50Method and devices for rapid diagnosis of foot-and-mouth disease
#51Diagnosing and treating hormone resistant cancers
#52Use of biomarkers for detecting ovarian cancer
#53Kit for measuring in vivo mutation frequency at an endogenous gene locus
#54Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#55Method and kit for detection of autoimmune chronic urticaria
#56Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#57Devices and methods for detecting amniotic fluid in vaginal secretions
#58Lipocalin-2 antibodies for methods of treatment
#59Assays for detection of Von Willebrand factor (vWF) multimers and for degradation of vWF by agents such as Adamts13 and related methods
#60Method for diagnosing rheumatoid arthritis via assaying myofibroblast-like synoviocytes for fibroblast activation protein
#61Method for Diagnosing Prognosing Inflammatory Bowel Disease and Crohn's Disease
#62Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
#63Food sensitivity testing in animals
#64HEALTH MONITORING AND DIAGNOSTIC DEVICE AND NETWORK-BASED HEALTH ASSESSMENT AND MEDICAL RECORDS MAINTENANCE SYSTEM
#65NOVEL METHODS FOR THE ASSAY OF TROPONIN I AND T AND COMPLEXES OF TROPONIN I AND T AND SELECTION OF ANTIBODIES FOR USE IN IMMUNOASSAYS
#66PREGNANCY AND SEX IDENTIFICATION TEST BASED ON SALIVA OR OTHER BODILY FLUIDS
#67Method for the rapid diagnosis of targets in human body fluids using undiluted samples
#68METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSOCIATED DISEASE
#69Determination of a specific immunoglobulin using multiple antigens
#70Cyclic peptide compositions for treatment of sexual dysfunction
#71Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes
#72Method for Diagnosing Diseases Based on Levels of Anti-Glycan Antibodies
#73Retentate chromatography and protein chip arrays with applications in biology and medicine
#74Method for Diagnosing Multiple Sclerosis
#75In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders
#76Perlecan fragments as biomarkers of bone stromal lysis
#77POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP
#78Quantitative analysis of in vivo mutation at the locus
#79Diagnostic tests of substance use disorders
#80Identification and monitoring of systemic lupus erythematosus
#81DIAGNOSING AND MONITORING INFLAMMATORY DISEASES BY MEASURING COMPLEMENT COMPONENTS ON WHITE BLOOD CELLS
#82Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
#83Method for detecting lysosomal storage diseases
#84Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
#85Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements
#86Prewetting lateral flow test strip
#87Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism
#88Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
#89Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
#90METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC IMMUNE DISEASES
#91Method for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP4, P2)
#92Retentate chromatography and protein chip arrays with applications in biology and medicine
#93Prostasin partial peptide and anti-prostasin antibody
#94Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
#95MULTIDIMENSIONAL MASS SPECTROMETRY OF SERUM AND CELLULAR LIPIDS DIRECTLY FROM BIOLOGIC EXTRACTS
#96Analytical sandwich test for determining NT-proBNP
#97Method for determining if a subject having type II diabetes has a kidney disorder
#98Methods and kits for detecting ITA in a biological sample
#99Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
#100Method for Characterizing Immune Disorders
#101Diagnosing and treating hormone resistant cancers
#102PREGNANCY AND SEX IDENTIFICATION TEST BASED ON SALIVA OR OTHER BODILY FLUIDS
#103Hepatitis-C virus type 4, 5 and 6
#104Novel morphogenic protein compositions of matter
#105In vitro method for the diagnosis of neurodegenerative diseases
#106Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#107METAL CHELATE-LABELLED PEPETIDES
#108Markers of renal transplant rejection and renal damage
#109Method of detecting platelet thrombosis or organ failure
#110Use of lipocalin-2 as a diagnostic marker and therapeutic target
#111Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
#112Detection and monitoring of liver damage
#113Methods for diagnosis of myelodysplastic syndromes (MDS)
#114Method for diagnosing immunologic food sensitivity
#115Uncoupled collagen synthesis and degradation assays
#116Flow cytometric method and kit for metal-induced sensitivity
#117Prewetting lateral flow test strip
#118Method of detecting thrombosis by measuring von Willenbrand factor-cleaving protease
#119Method for measuring in vivo mutation frequency at an endogenous gene locus
#120Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#121Identification and monitoring of systemic lupus erythematosus
#122Method for predicting sepsis or an acute infectious inflammatory response
#123Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
#124Hepatitis-C virus type 4, 5 and 6
#125Method of diagnosing myasthenia gravis and kits therefor
#126Methods and apparatus for screening for chromosomal abmormalities
#127Method for characterizing autoimmune disorders
#128Method for the rapid diagnosis of targets in human body fluids
#129METHOD OF DIAGNOSING ALZHEIMER'S DISEASE BY DETECTION OF CHLAMYDIA PNEUMONIAE
#130Method for diagnosis of alzheimer's disease
#131Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#132Diagnostic assay for stroke
#133Method of diagnosis of foot and mouth disease and the diagnostic kit
#134Method of detecting a subfraction of proBNP
#135Quantitative, high-throughput screening method for protein stability
#136Method of detecting a subfraction of proBNP
#137Biochemical marker for diagnosing a leukodystrophy
#138Method and kit for detection of autoimmune chronic urticaria
#139Retentate chromatography and protein chip arrays with applications in biology and medicine
#140Methods for predicting pregnancy outcome in a subject by hCG assay
#141Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells
#142Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
#143Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
#144Methods and compositions related to joint inflammation diseases
#145Devices and methods for detecting amniotic fluid in vaginal secretions
#146Protein biopolymer markers indicative of age matched control
#147Protein biopolymer markers indicative of age matched control
#148Protein biopolymer markers indicative of age matched control
#149Expression profile of prostate cancer
#150Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease
#151Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL
#152Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
#153Method and devices for rapid diagnosis of foot-and-mouth disease
#154Method of identifying therapeutic compounds for a treatment of hepatic disorders
#155Immunoassay method and kit to be used therein
#156Cyclic peptide compositions for treatment of sexual dysfunction
#157Method of detecting native proBNP
#158Method of detecting native proBNP
#159Simultaneous screening of multiple analytes
#160Saliva immunoassay for detection of antibodies for cardiovascular disease
#161Methods of diagnosing liver fibrosis
#162Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
#163Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements
#164Disease markers for early stage atherosclerosis
#165Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism
#166Cyclic peptides for treatment for cachexia
#167Point of care diagnostic systems
#168Cyclic peptides for treatment of cachexia
#169Point of care diagnostic systems
#170Influenza sensor
#171Real time method of detecting acute inflammatory conditions
#172Method of diagnosing nephrotic syndrome
#173Lidocaine analogs and methods of making and using same
#174Retentate chromatography and protein chip arrays with applications in biology and medicine
#175Multiple agent therapy for sexual dysfunction
#176Method for detecting lysosomal storage diseases
#177Diagnostic reagent for hepatitis C virus infection
#178Hepatitis-C virus type 4, 5 and 6
#179NPHP nucleic acids and proteins
#180Assays for diagnosis of thrombophilic disease
#181Method for the detection of viable microorganisms
#182Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
#183Method for the rapid diagnosis of targets in human body fluids
#184Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
#185Screening for gestational disorders
#186Method for diagnosing diseases based on levels of anti-glycan antibodies
#187Method for diagnosing diseases based on levels of anti-glycan antibodies
#188Analytical sandwich test for determining NT-proBNP
#189Hemoglobin assay for neonatal screening
#190Method for the diagnosis of sepsis with determination of soluble cytokeratin fragments
#191Methods for differentiating and monitoring parathyroid and bone status related diseases
#192Determination of a specific immunoglobulin using multiple antigens
#193Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau
#194Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
#195Use of biomarkers for detecting ovarian cancer
#196Biomarkers for differentiating between type 1 and type 2 diabetes
#197Assays for detection of von willebrand factor (vWF) multimers and for degradation of vWF by agents such as ADAMTS13 and related methods
#198Method of using physiological markers to estimate cardiovascular risk
#199Monitoring immunologic, hematologic and inflammatory diseases
#200Composition and methods for treatment of sexual dysfunction
#201Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
#202Hepatitis-C virus type 4, 5, and 6
#203Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same